Appropriate conversion from valproate monotherapy to lamotrigine monotherapy in Japanese women with epilepsy
Year: 2016
Type: article
Study design: Clinical Trial
Abstract: on behalf of the Lamictal 200776 Study GroupPurpose: Exposur e to sodium valpr oate (VPA) dur ing pr egnancy may incr ease the r isk of fetal malformations and cognitive developmental deficits.We therefore assessed a clinically practical method to change treatment from VPA monotherapy to lamotrigine (LTG) monotherapy in Japanese women of childbearing potential whose seizures were controlled by VPA. Methods:In an open-label, single arm, multicenter study, we evaluated the reduction in VPA dose and change in seizure frequency from baseline when VPA monotherapy was switched to LTG monotherapy in female patients by the following protocol.(1) The LTG dose was increased up to 200 mg/day while the initial VPA dose was maintained.(2) The VPA dose was reduced to 0 mg/day while the LTG dose was maintained.(3) When VPA was removed, the LTG dose was simultaneously increased by up to 100 mg/day.(4) The LTG dose was further adjusted.Due to the risk of break-through seizures during adjustment of VPA and LTG doses, LTG trough serum concentration was measured for seizure control.Results: Of 33 patients enr olled, 20 completed the entir e pr otocol, with VPA r emoval in 19 patients.Thirteen patients were withdrawn from the study during LTG escalation, mainly due to LTG-related skin rash (n = 8) in the early stage of LTG initiation (10 days on average).Seizures were observed once in 2 patients during LTG monotherapy (7 and 13 weeks after VPA removal).Discussions: By paying car eful attention to the occur r ence of skin r ash or any sign of hypersensitivity at the beginning of LTG escalation, Japanese women receiving VPA monotherapy can be converted to LTG monotherapy.
Source: Epilepsy & Seizure
DOI: 10.3805/eands.8.21
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G2245966152, G5285102892
OpenAlex ID: W2560893402
